The National Institutes of Health awarded the Laboratory of Applied Pharmacokinetics and Bioinformatics at the Children’s Hospital Los Angeles $2.8 million over four years to use artificial intelligence to anticipate dosing and target the condition of individual critically ill patients over…
Source: Healthcareitnews.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
